Until myBMI strengthens its communication, its reliability on paper will not fully match the confidence patients expect in practice
In addition to GLP-1/GIP/GCG receptors tri-agonists, there are also triagonists targeting Xenopus GLP-1/GCG/Cholecystokinin-2 (CCK2) receptors [107], GLP-1/GCG/ neuropeptide Y 2 receptors [108], and GLP-1R, neuropeptide Y1, and neuropeptide Y2 receptors [109]
Development of a novel drug delivery system to deliver drugs directly to the colonic mucosa, resulting in improved efficacy and reduced systemic exposure for the treatment of ulcerative colitis
New Formulations: Efforts are underway to create more convenient formulations, including longer-acting injectables that may only require monthly administration and improved oral versions
doi: 10.1016/j.jalz.2016.02.010 42 OttAStolkRPvan HarskampFPolsHAHofmanABretelerMM
and slow gastric emptying, leading to weight loss, which is beneficial for diabetic patients who are obese